These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 12795658
1. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B. Schiekofer S, Rudofsky G, Andrassy M, Schneider J, Chen J, Isermann B, Kanitz M, Elsenhans S, Heinle H, Balletshofer B, Häring HU, Schleicher E, Nawroth PP, Bierhaus A. Diabetes Obes Metab; 2003 Jul; 5(4):251-61. PubMed ID: 12795658 [Abstract] [Full Text] [Related]
2. Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes. Schiekofer S, Galasso G, Andrassy M, Aprahamian T, Schneider J, Rocnik E. Diabetes Obes Metab; 2006 Sep; 8(5):473-82. PubMed ID: 16918581 [Abstract] [Full Text] [Related]
3. Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway. Jojima T, Suzuki K, Hirama N, Uchida K, Hattori Y. Diabetes Obes Metab; 2009 Feb; 11(2):143-9. PubMed ID: 18564176 [Abstract] [Full Text] [Related]
4. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related]
5. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. Rudofsky G, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A. Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974 [Abstract] [Full Text] [Related]
6. Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal. Schiekofer S, Franke S, Andrassy M, Chen J, Rudofsky G, Schneider JG, von Eynatten M, Wendt T, Morcos M, Kientsch-Engel R, Stein G, Schleicher E, Nawroth PP, Bierhaus A. Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):160-7. PubMed ID: 16705547 [Abstract] [Full Text] [Related]
7. Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs. Rudofsky G, Reismann P, Schiekofer S, Petrov D, von Eynatten M, Humpert PM, Isermann B, Müller-Hoff C, Thai TP, Lichtenstein S, Bärtsch U, Hamann A, Nawroth P, Bierhaus A. Horm Metab Res; 2004 Sep; 36(9):630-8. PubMed ID: 15486815 [Abstract] [Full Text] [Related]
8. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Thiele K, Bierhaus A, Autschbach F, Hofmann M, Stremmel W, Thiele H, Ziegler R, Nawroth PP. Gut; 1999 Nov; 45(5):693-704. PubMed ID: 10517905 [Abstract] [Full Text] [Related]
9. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Rödel F, Hantschel M, Hildebrandt G, Schultze-Mosgau S, Rödel C, Herrmann M, Sauer R, Voll RE. Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793 [Abstract] [Full Text] [Related]
10. Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level. Andrassy M, Bierhaus A, Hong M, Sis J, Schiekofer S, Humper PM, Chen J, Haap M, Renn W, Schleicher E, Häring HU, Andrassy K, Nawroth PP. Clin Nephrol; 2002 Sep; 58(3):179-89. PubMed ID: 12357990 [Abstract] [Full Text] [Related]
11. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Schiekofer S, Andrassy M, Chen J, Rudofsky G, Schneider J, Wendt T, Stefan N, Humpert P, Fritsche A, Stumvoll M, Schleicher E, Häring HU, Nawroth PP, Bierhaus A. Diabetes; 2003 Mar; 52(3):621-33. PubMed ID: 12606501 [Abstract] [Full Text] [Related]
12. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Luis Bautista J, Bugos C, Dirnberger G, Atherton T. Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120 [Abstract] [Full Text] [Related]
13. Activation of tubular epithelial cells in diabetic nephropathy. Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP. Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911 [Abstract] [Full Text] [Related]
14. Glimepiride. A review of its use in the management of type 2 diabetes mellitus. Langtry HD, Balfour JA. Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345 [Abstract] [Full Text] [Related]
15. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL, Figgitt DP. Pharmacoeconomics; 2004 Apr; 22(6):389-411. PubMed ID: 15099124 [Abstract] [Full Text] [Related]
16. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: involvement of Syk tyrosine kinase. Yang WS, Seo JW, Han NJ, Choi J, Lee KU, Ahn H, Lee SK, Park SK. Am J Physiol Renal Physiol; 2008 May; 294(5):F1065-75. PubMed ID: 18353872 [Abstract] [Full Text] [Related]
17. Effects of exercise on cyclooxygenase-2 expression and nuclear factor-kappaB DNA binding in human peripheral blood mononuclear cells. Kim SY, Jun TW, Lee YS, Na HK, Surh YJ, Song W. Ann N Y Acad Sci; 2009 Aug; 1171():464-71. PubMed ID: 19723090 [Abstract] [Full Text] [Related]
18. [Regulatory effects of lanthanum chloride on the activation of nuclear factor kappa B inhibitor kinase beta induced by tumor necrosis factor alpha]. Guo F, He F, Xiu M, Lou YL, Xie A, Liu F, Li GH. Zhonghua Shao Shang Za Zhi; 2013 Dec; 29(6):531-6. PubMed ID: 24495640 [Abstract] [Full Text] [Related]
19. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha. Dichamp I, Bourgeois A, Dirand C, Herbein G, Wendling D. J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809 [Abstract] [Full Text] [Related]
20. Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: randomized controlled trial (PioRAGE). Koyama H, Tanaka S, Monden M, Shoji T, Morioka T, Fukumoto S, Mori K, Emoto M, Shoji T, Fukui M, Fujii H, Nishizawa Y, Inaba M. Atherosclerosis; 2014 Jun; 234(2):329-34. PubMed ID: 24727234 [Abstract] [Full Text] [Related] Page: [Next] [New Search]